Screener
Celldex Therapeutics CLDX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Celldex Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
FAQ
- What is Celldex Therapeutics's operating margin?
- Celldex Therapeutics (CLDX) reported operating margin of -206,220.3% in Q2 2026.
- How has Celldex Therapeutics's operating margin changed year-over-year?
- Celldex Therapeutics's operating margin decreased by 4987.2% year-over-year, from -4,053.7% to -206,220.3%.
- What is the long-term trend for Celldex Therapeutics's operating margin?
- Over 5 years (2020 to 2025), Celldex Therapeutics's operating margin has grown at a 85.2% compound annual growth rate (CAGR), from -854.1% to -18,587.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Celldex Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude